Our News on Newswise

MD Anderson Research Highlights for March 7, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
7-Mar-2024 12:00 PM EST Add to Favorites

Newswise: 65de120348596_149163KadaraH.jpg

Study unravels the earliest cellular genesis of lung adenocarcinoma

Researchers at The University of Texas MD Anderson Cancer Center built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most common type of lung cancer. These findings,...
27-Feb-2024 11:05 AM EST Add to Favorites

MD Anderson acquires inducible switch technologies for cell therapy

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may incorporate these technologies into its own cell therapy programs as well as make them...
23-Feb-2024 2:45 PM EST Add to Favorites

MD Anderson researchers receive over $25.5 million in CPRIT funding

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs,...
21-Feb-2024 4:00 PM EST Add to Favorites

MD Anderson Research Highlights for February 21, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
21-Feb-2024 12:00 PM EST Add to Favorites

Immunotherapy before surgery leads to promising long-term survival in sarcoma patients

Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the time of surgery and promising long-term survival, according to Phase II trial results published today in Nature Cancer...
12-Feb-2024 5:05 PM EST Add to Favorites

Newswise: 65ca922b1a64f_johnheymach.jpg.resize.405.575.high.jpg

Biomarker-directed combination effective in immunotherapy-resistant lung cancer

A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from...
12-Feb-2024 5:00 PM EST Add to Favorites

MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

MD Anderso and C-Biomex today announced a strategic collaboration to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.
7-Feb-2024 5:00 PM EST Add to Favorites


See All News

Our Experts on Newswise

Newswise: BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Newswise: Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

Newswise: ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Newswise: Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

Newswise: 204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

See All Experts

Our YouTube Videos

About

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation’s first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings and has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

Experts

Contacts

Aubrey Bloom
Program Manager, Public Relations

ARBloom@mdanderson.org

830-377-8566

Clayton Boldt
Program Director, Public Relations

CRBoldt@MDAnderson.org

713-792-9518

Andrea Bolt
Sr. Communications Specialist

ARBolt@MDAnderson.org

Katrina Burton
Program Manager, Public Relations

kburton@mdanderson.org

713-792-8034

Lany Kimmons
Program Manager, Public Relations

rlkimmons@mdanderson.org

713-563-5801

Jamie Mauracher
Program Manager

JRMauracher@MDAnderson.org

Julie Nagy
Program Manager, Public Relations

jenagy@mdanderson.org

713-563-3437

Elise Raymund
Sr. Communication Specialist

ERRaymund@mdanderson.org

346-725-0943

Allison Schaffer
Program Manager, Public Relations

ASchaffer@mdanderson.org

713-745-1357

Jade Waddy
Program Manager, Public Relations

JAWaddy@mdanderson.org

346-725-2126

Twitter

close
1.38124